CSPC Pharmaceutical GroupCSPCY +9.27%79 Pretax Margin % is 8.27% as of Dec. 2025, which is 62% below its 10-year median of 21.91. GuruFocus rates CSPCY with a GF Score™ of 79/100 and a GF Value™ of $3.37 (Fairly Valued). The stock has 4 warning signs investors should review. Among 952 Drug Manufacturers companies, CSPC Pharmaceutical Group ranks better than 73.11% on this metric.
The historical rank and industry rank for CSPC Pharmaceutical Group's Pretax Margin % or its related term are showing as below:
CSPCY'
s Pretax Margin % Range Over the Past 10 Years
Min: 16.28 Med: 21.91 Max: 25.62
Current: 16.28
CSPCY's Pretax Margin % is ranked better than 73.11% of 952
companies
in the Drug Manufacturers industry
Industry Median: 7.295
vs CSPCY: 16.28
CSPC Pharmaceutical Group (OTCPK:CSPCY) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
CSPC Pharmaceutical Group Pretax Margin % Related Terms
CSPC Pharmaceutical Group Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CSPCY vs LLY, JNJ, ABBV: Pretax Margin % Comparison
For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CSPC Pharmaceutical Group Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where CSPC Pharmaceutical Group's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CSPC Pharmaceutical Group (CSPCY) has a Pretax Margin % of 8.27% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on CSPC Pharmaceutical Group and its competitors. This is 62% below median its historical median of 21.91. Over the past decade, CSPC Pharmaceutical Group's Pretax Margin % has ranged from 16.28 to 25.62. According to the industry distribution chart, CSPC Pharmaceutical Group ranks #256 out of 952 companies in the Drug Manufacturers industry, placing it in the top 26.9%.
Is CSPC Pharmaceutical Group's Pretax Margin % too high?
CSPC Pharmaceutical Group's current Pretax Margin % of 8.27% is 62% below median its 10-year median of 21.91. Over the past 10 years, this metric has ranged from a low of 16.28 to a high of 25.62. The Drug Manufacturers industry median Pretax Margin % is 7.30. CSPC Pharmaceutical Group's value of 8.27% is 13.4% above this industry median. Based on the distribution chart, CSPC Pharmaceutical Group ranks #256 out of 952 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, CSPC Pharmaceutical Group has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CSPC Pharmaceutical Group's Pretax Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, CSPC Pharmaceutical Group ranks #256 out of 952 companies for Pretax Margin %. This puts CSPC Pharmaceutical Group in the upper half of its industry. The industry median Pretax Margin % is 7.30. CSPC Pharmaceutical Group's value of 8.27% is 13.4% above this benchmark. Historically, CSPC Pharmaceutical Group's own Pretax Margin % has ranged from 16.28 to 25.62 over the past decade. While the company's 10-year median is 21.91 vs. the industry median of 7.30, CSPC Pharmaceutical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.30, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CSPC Pharmaceutical Group's current Pretax Margin % of 8.27% is 13.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on CSPC Pharmaceutical Group and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CSPC Pharmaceutical Group's current Pretax Margin % is 8.27%, which is 62% below median its own 10-year median of 21.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CSPC Pharmaceutical Group stock overvalued right now?
Based on GuruFocus' analysis, CSPC Pharmaceutical Group (CSPCY) is currently considered Fairly Valued. The stock's GF Value™ is $3.37, compared to a current price of $3.58 — trading 6.4% above its estimated fair value. The current Pretax Margin % is 8.27%, which is 62% below median its 10-year median of 21.91 and 13.4% above the Drug Manufacturers industry median of 7.30. CSPC Pharmaceutical Group's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For CSPC Pharmaceutical Group (CSPCY), the current Pretax Margin % is 8.27% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CSPC Pharmaceutical Group (CSPCY) Overvalued in 2026?
Based on GuruFocus' analysis, CSPC Pharmaceutical Group stock appears to be overvalued.
The current stock price of $3.58 is trading 6.4% above its estimated GF Value™ of $3.37.
GuruFocus considers CSPC Pharmaceutical Group to be Fairly Valued.
Key valuation signals for CSPCY:
Pretax Margin %: 8.27% (62% below median its 10-year median of 21.91)
GF Value™: $3.37 vs. price of $3.58 (6.4% above fair value)
Industry Position: 13.4% above the Drug Manufacturers median (#256 of 952)
No single metric tells the full story. See the CSPCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CSPC Pharmaceutical Group LTD is engaged in the manufacture and sale of pharmaceutical products. The group's segments include: Finished drugs, consisting research and development, manufacture and sale of pharmaceutical products and license fee income; Bulk products, that manufacture and sale of vitamin C, and antibiotic products in bulk powder form; and Functional food and others, that manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. It derives maximum revenue from Finished Products segments. Geographically, the company operates in Chinese Mainland, which Chinese Mainland generates maximum revenue; Other Asian regions; Europe; North America; and Others.
79GF Score
Get the complete analysis for CSPCY
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSPCY has been successfully added to your 
